HBx and HBs regulate RhoC expression by upregulating transcription factor Ets-1

HBx and HBs regulate RhoC expression by upregulating transcription factor Ets-1 The available evidence suggests that HBV proteins play an important role in the development of hepatocellular carcinoma (HCC). RhoC, a member of the Rho subfamily of the Ras superfamily of homologous genes, had been implicated in tumorigenesis and tumor progression. In a previous study, we demonstrated that HBx and HBs could up-regulate RhoC expression by enhancing its promoter activity. However, the specific mechanisms remain unclear. Here, we demonstrate that overexpression of Ets-1 results in upregulation of RhoC promoter activity and mRNA and protein levels. Expression of transcription factor Ets-1 was significantly higher in HepG2.2.15 cells than that in HepG2 cells. Meanwhile, infection of HepG2 cells with an HBV-adenovirus recombinant virus led to up-regulation of Ets-1. Of the four HBV proteins, HBx and HBs, could increase expression of Ets-1, which consequently contributed to the upregulation of RhoC. These findings might provide a novel insight into HBV-induced HCC metastasis. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Virology Springer Journals

HBx and HBs regulate RhoC expression by upregulating transcription factor Ets-1

Loading next page...
 
/lp/springer_journal/hbx-and-hbs-regulate-rhoc-expression-by-upregulating-transcription-0uzKJ9Ucs2
Publisher
Springer Vienna
Copyright
Copyright © 2013 by Springer-Verlag Wien
Subject
Biomedicine; Virology; Medical Microbiology; Infectious Diseases
ISSN
0304-8608
eISSN
1432-8798
D.O.I.
10.1007/s00705-013-1655-1
Publisher site
See Article on Publisher Site

References

  • Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
    El-Serag, HB; Rudolph, KL
  • ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression
    Kato, T; Fujita, Y; Nakane, K; Kojima, T; Nozawa, Y; Deguchi, T; Ito, M
  • Ets-1 transcription is required in tissue factor driven microvessel formation and stabilization
    Gemma, A; Esther, P; Rosa, A; Sonia, E; Lina, B
  • Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas
    Alipov, G; Nakayama, T; Ito, M; Kawai, K; Naito, S; Nakashima, M; Niino, D; Sekine
  • Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer
    Sasaki, H; Yukiue, H; Moiriyama, S; Kobayashi, Y; Nakashima, Y; Kaji, M; Kiriyama, M; Fukai, I; Yamakawa, Y; Fujii, Y

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial